Title: Chief Executive Officer
Company: TimeYodha
Location: Del Mar, California, United States
Dr. Rajesh Grover, chief executive officer at TimeYodha, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in health care and technology.
With over two and a half decades of experience, Dr. Grover has built a distinguished career as an entrepreneur, specializing in health, well-being, and predictive technology. He currently serves as a strategic adviser for Marqi Health Inc. and Nobody Studios, both since 2023, chief executive officer of TimeYodha since 2022, co-founder of Mange Bene and founder of AJELES Inc., both since 2020, and managing director of SuperGrover LLC since 2017. His previous roles include strategic adviser at KittyHawk Ventures in 2020 and Houston Healthspan Innovation Group from 2019 to 2020, director of scientific innovations at Carlyle Global Partners from 2017 to 2020, and adjunct professor at the J. Craig Venter Institute from 2017 to 2019. Earlier in his career, he was co-founder and chief of the scientific advisory board for Nurish.Me from 2017 to 2019, visiting investigator at the J. Craig Venter Institute from 2017 to 2018, and assistant professor in the Department of Cell and Molecular Biology at The Scripps Research Institute from 2014 to 2017. He also held positions as senior staff scientist at The Scripps Research Institute from 2007 to 2014, vice president of corporate relations at UC San Diego’s Entrepreneur Challenge from 2011 to 2012, and trainee officer at Cadila Pharmaceuticals Limited in India from 1998 to 1999.
Dr. Grover laid a solid educational foundation, earning a PhD in drug discovery and biomedical magnetic resonance from the Central Drug Research Institute in Lucknow, India, in 2004, a master’s degree in chemistry, biochemistry, polymer engineering, and biomedical engineering from the Indian Institute of Technology in Delhi in 1998, and completed a postdoctoral fellowship in chemical biology and immunology at Scripps Research in 2007. He has also dedicated his time as a member of the board of advisers for GLO Good Foundation since 2023, member of the executive board for the UC San Diego Entrepreneur Challenge since 2012, and board member of the American Nutrition Association from 2018 to 2023. Additionally, he is affiliated with organizations such as the American Association for the Advancement of Science, Sigma Xi, and the American Society of Hematology.
Dr. Grover has made significant contributions to his field, including co-creating “Risking Aspirations—A Film” in 2014 and authoring influential publications such as “A Structurally Distinct Human Mycoplasma Protein that Generically Blocks Antigen-Antibody Union” and “The Costimulatory Immunogen LPS Induces the B-Cell Clones that Infiltrate Transplanted Human Kidneys.” His groundbreaking discoveries include a tuberculosis drug, the Napoleon Complex (Protein M) in Mycoplasma genitalium, and the evasion mechanism of kinetoplastids. His work has been featured in Science Magazine, JAMA, Nature Reviews, American Journal of Transplantation, and media outlets such as PBS, Der Spiegel, San Diego Union-Tribune, and FOX. He has received prestigious fellowships with Richard Lerner at Harvard Medical School, Savannah College of Art and Design, and the Marie Meyer Scholarship for developing a skin cancer vaccine. He attributes his success to determination, persistence, and a passion for serving others. Looking ahead, he aspires to be featured on the cover of Fortune or Forbes.
For more information, please visit:
Contact name:
